These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 228890

  • 1. Epstein--Barr virus-associated antibodies in IgG and IgA of nasopharyngeal carcinoma patients.
    Yang CS, Yang HM, Yeh YS, Lynn TC.
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):167-75. PubMed ID: 228890
    [No Abstract] [Full Text] [Related]

  • 2. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
    Desgranges C, de-The G.
    IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
    Ho HC, Ng MH, Kwan HC.
    Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619
    [No Abstract] [Full Text] [Related]

  • 5. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
    Ho HC, Ng MH, Kwan HC, Chau JC.
    Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437
    [Abstract] [Full Text] [Related]

  • 6. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W, Henle G, Ho JH.
    IARC Sci Publ (1971); 1978 Mar; (20):427-37. PubMed ID: 215525
    [No Abstract] [Full Text] [Related]

  • 8. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.
    Desgranges C, De-Thé G, Ho JH, Ellouz R.
    Int J Cancer; 1977 May 15; 19(5):627-33. PubMed ID: 193801
    [Abstract] [Full Text] [Related]

  • 9. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
    Xia C, Zhu K, Zheng G.
    Int J Clin Exp Pathol; 2015 May 15; 8(12):16104-10. PubMed ID: 26884888
    [Abstract] [Full Text] [Related]

  • 10. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX, Zeng Y, Wolf H.
    Int J Cancer; 1986 May 15; 37(5):689-91. PubMed ID: 3009331
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.
    Dardari R, Khyatti M, Benider A, Jouhadi H, Kahlain A, Cochet C, Mansouri A, El Gueddari B, Benslimane A, Joab I.
    Int J Cancer; 2000 Apr 01; 86(1):71-5. PubMed ID: 10728597
    [Abstract] [Full Text] [Related]

  • 12. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
    Vera Sempere FJ.
    Med Clin (Barc); 1992 May 16; 98(19):758-9. PubMed ID: 1318986
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma.
    Cai YL, Li J, Lu AY, Zheng YM, Zhong WM, Wang W, Gao JQ, Zeng H, Cheng JR, Tang MZ.
    Asian Pac J Cancer Prev; 2014 May 16; 15(5):2001-6. PubMed ID: 24716925
    [Abstract] [Full Text] [Related]

  • 14. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
    Foong YT, Cheng HM, Sam CK, Dillner J, Hinderer W, Prasad U.
    Int J Cancer; 1990 Jun 15; 45(6):1061-4. PubMed ID: 1693600
    [Abstract] [Full Text] [Related]

  • 15. EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells.
    Desgranges C, Li JY, De-Thé.
    Int J Cancer; 1977 Dec 15; 20(6):881-6. PubMed ID: 201574
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY, Lau YK, Chia KB, Lim CH.
    Singapore Med J; 1988 Jun 15; 29(3):257-60. PubMed ID: 2847323
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas.
    Desgranges C, de-Thé G.
    Int J Cancer; 1979 Nov 15; 24(5):555-9. PubMed ID: 231014
    [Abstract] [Full Text] [Related]

  • 18. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Nov 15; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May 15; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, Rumpianesi F.
    J Infect; 1986 Mar 15; 12(2):127-31. PubMed ID: 3009628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.